Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Head & Neck 1Breast 1

Conditions

Breast Neoplasms 12Neoplasms 4Recurrence 3Squamous Cell Carcinoma of Head and Neck 2Neoplasms by Site 2Neoplasm Metastasis 2Head and Neck Neoplasms 2Endometrial Neoplasms 2Breast Diseases 2Brain Neoplasms 2Uterine Cervical Neoplasms 1Unilateral Breast Neoplasms 1Triple Negative Breast Neoplasms 1Spinal Cord Neoplasms 1Recurrent Ovarian High Grade Serous Adenocarcinoma 1Ovarian Neoplasms 1Neurofibromatosis 1 1Neoplasms, Squamous Cell 1Multiple Myeloma 1Meningioma 1Lymphoma, Non-Hodgkin 1Locally Advanced (Inoperable) or Metastatic Breast Cancer 1Liposarcoma 1Hereditary Sensory and Autonomic Neuropathies 1HR+/HER2- Breast Cancer 1Glioma 1Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1Central Nervous System Neoplasms 1Central Nervous System Diseases 1Brain Diseases 1

Interventions

pembrolizumab 14Paclitaxel 12Carboplatin 11Bevacizumab 7Specimen Handling 6Taxes 5Fulvestrant 5Cisplatin 5olaparib 4Nivolumab 4Magnetic Resonance Spectroscopy 4Biopsy 4palbociclib 3Oxaliplatin 3Megestrol Acetate 3Leucovorin 3Letrozole 3Immunoglobulin G 3Fluorouracil 3Doxorubicin 3Docetaxel 3Disulfides 3trastuzumab deruxtecan 2ribociclib 2pertuzumab 2lenvatinib 2ipatasertib 2durvalumab 2dostarlimab 2capivasertib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Endometrial Neoplasms × abemaciclib × 30 days × Clear all
NCT05768139 2026-06-04

PIKALO-1

Eli Lilly and Company

Phase 1/2 Recruiting
880 enrolled
BreastGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Breast Diseases, Breast Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Neoplasms, Neoplasms by Site, Hereditary Sensory and Autonomic Neuropathies, Ovarian Neoplasms, Endometrial Neoplasms

NCT07209449 2026-05-22

A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
75 enrolled
Gynecologic

Recurrence, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡